Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs CONCORD DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA CONCORD DRUGS ASTRAZENECA PHARMA/
CONCORD DRUGS
 
P/E (TTM) x 193.4 -70.8 - View Chart
P/BV x 22.4 1.2 1,935.4% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ASTRAZENECA PHARMA   CONCORD DRUGS
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-24
CONCORD DRUGS
Mar-23
ASTRAZENECA PHARMA/
CONCORD DRUGS
5-Yr Chart
Click to enlarge
High Rs7,20842 17,306.1%   
Low Rs3,10220 15,907.7%   
Sales per share (Unadj.) Rs518.255.9 927.4%  
Earnings per share (Unadj.) Rs64.61.1 6,106.6%  
Cash flow per share (Unadj.) Rs70.62.8 2,519.4%  
Dividends per share (Unadj.) Rs24.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs283.533.4 848.4%  
Shares outstanding (eoy) m25.009.32 268.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x9.90.5 1,819.0%   
Avg P/E ratio x79.828.9 276.1%  
P/CF ratio (eoy) x73.010.9 669.5%  
Price / Book Value ratio x18.20.9 1,988.3%  
Dividend payout %37.10-   
Avg Mkt Cap Rs m128,875285 45,247.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,41538 6,289.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,955521 2,487.5%  
Other income Rs m3480 386,666.7%   
Total revenues Rs m13,303521 2,554.0%   
Gross profit Rs m2,00946 4,393.7%  
Depreciation Rs m14916 918.8%   
Interest Rs m1217 70.3%   
Profit before tax Rs m2,19512 17,577.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5803 22,064.6%   
Profit after tax Rs m1,61510 16,380.3%  
Gross profit margin %15.58.8 176.6%  
Effective tax rate %26.421.1 125.3%   
Net profit margin %12.51.9 658.8%  
BALANCE SHEET DATA
Current assets Rs m10,427435 2,399.5%   
Current liabilities Rs m4,672216 2,161.2%   
Net working cap to sales %44.441.9 105.9%  
Current ratio x2.22.0 111.0%  
Inventory Days Days477 722.1%  
Debtors Days Days431,108 3.9%  
Net fixed assets Rs m2,342148 1,584.8%   
Share capital Rs m5093 53.7%   
"Free" reserves Rs m7,036218 3,224.1%   
Net worth Rs m7,086311 2,275.6%   
Long term debt Rs m019 0.0%   
Total assets Rs m12,769582 2,192.8%  
Interest coverage x184.01.7 10,619.9%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.00.9 113.4%   
Return on assets %12.74.6 275.7%  
Return on equity %22.83.2 720.2%  
Return on capital %31.28.9 348.4%  
Exports to sales %00-   
Imports to sales %0.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m61NA-   
Fx inflow Rs m1,0940-   
Fx outflow Rs m610-   
Net fx Rs m1,0330-   
CASH FLOW
From Operations Rs m27917 1,675.9%  
From Investments Rs m217-23 -959.4%  
From Financial Activity Rs m-4446 -7,112.2%  
Net Cashflow Rs m520 23,772.7%  

Share Holding

Indian Promoters % 0.0 54.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.0 0.0 -  
FIIs % 2.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 45.6 54.8%  
Shareholders   27,615 5,073 544.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on ASTRAZENECA PHARMA vs CONCORD DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs CONCORD DRUGS Share Price Performance

Period ASTRAZENECA PHARMA CONCORD DRUGS S&P BSE HEALTHCARE
1-Day 0.76% 0.64% 1.23%
1-Month -11.78% -0.91% -0.24%
1-Year 35.77% 1.10% 43.62%
3-Year CAGR 28.31% 7.32% 20.35%
5-Year CAGR 19.26% 13.62% 26.24%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the CONCORD DRUGS share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of CONCORD DRUGS the stake stands at 54.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of CONCORD DRUGS.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 24.0 per share. This amounted to a Dividend Payout ratio of 37.1%.

CONCORD DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of CONCORD DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.